Cupertino Therapeutics is categorized under Research and Development Laboratories in Cupertino, CA and active since 2010.
Cupertino Therapeutics was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Sally A Berry at the company’s single location by writing to 20450 Stevens Creek Boulevard, Cupertino, California CA 95014 or by phoning (650) 787-4040. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cupertino Therapeutics |
| Contact Person: | Sally A Berry |
| Address: | 20450 Stevens Creek Boulevard, Cupertino, California 95014 |
| Phone Number: | (650) 787-4040 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Cupertino Therapeutics was started in 2010 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Sally A Berry for inquiries that concern Cupertino Therapeutics by calling the company number (650) 787-4040, as your correspondence is most welcome. Additionally, the physical location of the single location of Cupertino Therapeutics can be found at the coordinates 37.322683,-122.030352 as well as the street address 20450 Stevens Creek Boulevard in Cupertino, California 95014.
For its online presence, you may visit Cupertino Therapeutics’s website at and engage with its social media outlets through on Twitter and on Facebook.